Who is the CEO of Neurosense Therapeutics Ltd?

Mr. Alon Ben-Noon is the Chief Executive Officer of Neurosense Therapeutics Ltd, joining the firm since 2017.

What is the price performance of NRSN stock?

The current price of NRSN is $0.8099, it has increased 6.28% in the last trading day.

What are the primary business themes or industries for Neurosense Therapeutics Ltd?

Neurosense Therapeutics Ltd belongs to Biotechnology industry and the sector is Health Care

What is Neurosense Therapeutics Ltd market cap?

Neurosense Therapeutics Ltd's current market cap is $28.6M

Is Neurosense Therapeutics Ltd a buy, sell, or hold?

According to wall street analysts, 6 analysts have made analyst ratings for Neurosense Therapeutics Ltd, including 2 strong buy, 4 buy, 2 hold, 0 sell, and 2 strong sell

Neurosense Therapeutics Ltd (NRSN) Stock Price, Chart, News and AI analysis



NRSN

NRSN Price

Neurosense Therapeutics Ltd

$0.8

6.28%

$0.04

As of today:May 20, 16:53:28 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.762

Open

$0.8

Day's Range

$0.7603 - $0.8598

52 week range

$0.63 - $2.6

Volume

71.3K

Avg.Volume

207.4K

Dividend yield

EPS (TTM)

-0.62

Market Cap

$28.6M

What is NRSN?

Neurosense Therapeutics Ltd. is a clinical-stage biotechnology company. The firm is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The firm's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease

Features

Markets

News

Neurosense Therapeutics Ltd (NRSN) Price

NRSN Stock Price Chart